These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
490 related articles for article (PubMed ID: 17023779)
21. Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition. Stroup SP; Cullen J; Auge BK; L'Esperance JO; Kang SK Cancer; 2007 Sep; 110(5):1003-9. PubMed ID: 17614338 [TBL] [Abstract][Full Text] [Related]
22. Postradiotherapy 2-year prostate-specific antigen nadir as a predictor of long-term prostate cancer mortality. Zelefsky MJ; Shi W; Yamada Y; Kollmeier MA; Cox B; Park J; Seshan VE Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1350-6. PubMed ID: 19515504 [TBL] [Abstract][Full Text] [Related]
23. Unification of a common biochemical failure definition for prostate cancer treated with brachytherapy or external beam radiotherapy with or without androgen deprivation. Fitch DL; McGrath S; Martinez AA; Vicini FA; Kestin LL Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1430-9. PubMed ID: 16765527 [TBL] [Abstract][Full Text] [Related]
24. The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancer. D'Ambrosio DJ; Hanlon AL; Al-Saleem T; Feigenberg SJ; Horwitz EM; Uzzo RG; Pollack A; Buyyounouski MK Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1082-7. PubMed ID: 17241749 [TBL] [Abstract][Full Text] [Related]
25. Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy. Cheung R; Tucker SL; Lee AL; Dong L; Kamat A; Pisters L; Kuban DA Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):14-9. PubMed ID: 15629589 [TBL] [Abstract][Full Text] [Related]
26. PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: a study of 295 patients with a minimum 3-year followup. Toledano A; Chauveinc L; Flam T; Thiounn N; Solignac S; Timbert M; Rosenwald JC; Cosset JM Brachytherapy; 2006; 5(2):122-6. PubMed ID: 16644467 [TBL] [Abstract][Full Text] [Related]
27. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471 [TBL] [Abstract][Full Text] [Related]
28. Prostate-specific antigen bounce after intensity-modulated radiotherapy for prostate cancer. Sheinbein C; Teh BS; Mai WY; Grant W; Paulino A; Butler EB Urology; 2010 Sep; 76(3):728-33. PubMed ID: 19616279 [TBL] [Abstract][Full Text] [Related]
29. External beam radiotherapy for clinically node-negative, localized hormone-refractory prostate cancer: impact of pretreatment PSA value on radiotherapeutic outcomes. Akimoto T; Kitamoto Y; Saito J; Harashima K; Nakano T; Ito K; Yamamoto T; Kurokawa K; Yamanaka H; Takahashi M; Mitsuhashi N; Niibe H Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):372-9. PubMed ID: 15145150 [TBL] [Abstract][Full Text] [Related]
30. Quantifying the impact of seminal vesicle invasion identified using endorectal magnetic resonance imaging on PSA outcome after radiation therapy for patients with clinically localized prostate cancer. Nguyen PL; Whittington R; Koo S; Schultz D; Cote KB; Loffredo M; Tempany CM; Titelbaum DS; Schnall MD; Renshaw AA; Tomaszewski JE; D'Amico AV Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):400-5. PubMed ID: 15145155 [TBL] [Abstract][Full Text] [Related]
31. Biochemical failure and the temporal kinetics of prostate-specific antigen after radiation therapy with androgen deprivation. Buyyounouski MK; Hanlon AL; Horwitz EM; Uzzo RG; Pollack A Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1291-8. PubMed ID: 15817330 [TBL] [Abstract][Full Text] [Related]
32. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Demanes DJ; Rodriguez RR; Schour L; Brandt D; Altieri G Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1306-16. PubMed ID: 15817332 [TBL] [Abstract][Full Text] [Related]
33. Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy. Zelefsky MJ; Marion C; Fuks Z; Leibel SA J Urol; 2003 Nov; 170(5):1828-32. PubMed ID: 14532785 [TBL] [Abstract][Full Text] [Related]
34. Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer. Zelefsky MJ; Ben-Porat L; Scher HI; Chan HM; Fearn PA; Fuks ZY; Leibel SA; Venkatraman ES J Clin Oncol; 2005 Feb; 23(4):826-31. PubMed ID: 15681527 [TBL] [Abstract][Full Text] [Related]
35. Failure to achieve a PSA level Mitchell DM; McAleese J; Park RM; Stewart DP; Stranex S; Eakin RL; Houston RF; O'Sullivan JM Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1467-71. PubMed ID: 17689886 [TBL] [Abstract][Full Text] [Related]
36. First-year PSA kinetics and minima after prostate cancer radiotherapy are predictive of overall survival. Cheung R; Tucker SL; Kuban DA Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):20-4. PubMed ID: 16814948 [TBL] [Abstract][Full Text] [Related]
37. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy. Ho AY; Burri RJ; Cesaretti JA; Stone NN; Stock RG Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):16-22. PubMed ID: 19289266 [TBL] [Abstract][Full Text] [Related]
38. Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis. Horwitz EM; Thames HD; Kuban DA; Levy LB; Kupelian PA; Martinez AA; Michalski JM; Pisansky TM; Sandler HM; Shipley WU; Zelefsky MJ; Hanks GE; Zietman AL J Urol; 2005 Mar; 173(3):797-802. PubMed ID: 15711272 [TBL] [Abstract][Full Text] [Related]
39. Tumor control outcomes of patients treated with trimodality therapy for locally advanced prostate cancer. Copp H; Bissonette EA; Theodorescu D Urology; 2005 Jun; 65(6):1146-51. PubMed ID: 15922433 [TBL] [Abstract][Full Text] [Related]
40. [PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure]. Toledano A; Chauveinc L; Flam T; Thiounn N; Solignac S; Timbert M; Rosenwald JC; Cosset JM Cancer Radiother; 2007 May; 11(3):105-10. PubMed ID: 17158082 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]